Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Ocular Therapeutix, Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
123
−5 vs. Q1 2022
Shares held
44.3M
+943.8K (+2.2%) vs. Q1 2022
Total value
$178.2M
−$36.5M (−17.0%) vs. Q1 2022
New holders
16
40 more added
Sold out
21
36 more reduced

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OCUL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 123 institutions
Q1 2021: 154 institutionsQ2 2021: 149 institutionsQ3 2021: 141 institutionsQ4 2021: 140 institutionsQ1 2022: 132 institutionsQ2 2022: 123 institutionsQ3 2022: 130 institutionsQ4 2022: 116 institutionsQ1 2023: 127 institutionsQ2 2023: 135 institutionsQ3 2023: 114 institutionsQ4 2023: 119 institutionsQ1 2024: 147 institutionsQ2 2024: 151 institutionsQ3 2024: 168 institutionsQ4 2024: 180 institutionsQ1 2025: 197 institutionsQ2 2025: 187 institutionsQ3 2025: 216 institutionsQ4 2025: 249 institutionsQ1 2026: 271 institutionsQ2 2026: 262 institutions
Value heldQ2 2022: $178.2M
Q1 2021: $774.9MQ2 2021: $685.8MQ3 2021: $445.7MQ4 2021: $289.1MQ1 2022: $215.4MQ2 2022: $178.2MQ3 2022: $177.6MQ4 2022: $111.3MQ1 2023: $213.8MQ2 2023: $224.2MQ3 2023: $127.0MQ4 2023: $328.8MQ1 2024: $1.12BQ2 2024: $939.8MQ3 2024: $1.22BQ4 2024: $1.14BQ1 2025: $1.01BQ2 2025: $1.45BQ3 2025: $2.20BQ4 2025: $2.33BQ1 2026: $1.77BQ2 2026: $2.03B
Institutions holding OCUL and their total value by quarter
QuarterHoldersValue
Q2 2026262$2.03B
Q1 2026271$1.77B
Q4 2025249$2.33B
Q3 2025216$2.20B
Q2 2025187$1.45B
Q1 2025197$1.01B
Q4 2024180$1.14B
Q3 2024168$1.22B
Q2 2024151$939.8M
Q1 2024147$1.12B
Q4 2023119$328.8M
Q3 2023114$127.0M
Q2 2023135$224.2M
Q1 2023127$213.8M
Q4 2022116$111.3M
Q3 2022130$177.6M
Q2 2022123$178.2M
Q1 2022132$215.4M
Q4 2021140$289.1M
Q3 2021141$445.7M
Q2 2021149$685.8M
Q1 2021154$774.9M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Ocular Therapeutix, Inc; share changes are against Q1 2022.

Institutions holding OCUL in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Renaissance Technologies LLC381,500$1.53M0.00%−129,305−25.3%Reduced
Two Sigma Advisers, LP389,100$1.56M0.00%−296,000−43.2%Reduced
Goldman Sachs Group Inc468,248$1.88M0.00%+83,858+21.8%Added
UBS Oconnor LLC512,886$2.06M0.02%+512,886New
Bank of Montreal511,195$2.16M0.00%+300,258+142.3%Added
Banco Santander, S.A.555,884$2.23M0.03%+555,884New
Cetera Investment Advisers599,150$2.41M0.04%+32,400+5.7%Added
Northern Trust Corp667,581$2.68M0.00%−61,579−8.4%Reduced
Altium Capital Management LP695,000$2.79M1.18%00.0%Unchanged
D. E. Shaw & Co., Inc.748,465$3.01M0.00%+134,927+22.0%Added
Endurant Capital Management LP760,228$3.06M1.17%−163,735−17.7%Reduced
MSD Partners, L.P.1,016,302$4.09M0.31%+1,016,302New
Emerald Mutual Fund Advisers Trust1,044,732$4.20M0.24%−48,416−4.4%Reduced
Federated Hermes, Inc.1,192,072$4.79M0.01%+569,792+91.6%Added
Geode Capital Management, LLC1,351,425$5.43M0.00%−12,545−0.9%Reduced
State Street Corp1,411,827$5.68M0.00%−293,107−17.2%Reduced
Emerald Advisers, LLC1,465,702$5.89M0.30%+173,797+13.5%Added
Citadel Advisors LLC1,723,993$6.93M0.01%+31,657+1.9%Added
Deltec Asset Management LLC2,069,313$8.32M1.95%−7,000−0.3%Reduced
Vanguard Group Inc3,898,551$15.7M0.00%−296,855−7.1%Reduced
BlackRock Inc.4,795,603$19.3M0.00%−273,718−5.4%Reduced
Summer Road LLC5,944,761$23.9M100.00%00.0%Unchanged
Opaleye Management Inc.5,974,800$24.0M10.83%00.0%Unchanged
Two Sigma Investments, LP0$00.00%−483,284−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−174,967−100.0%Sold out
Swiss National Bank0$00.00%−172,100−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−101,123−100.0%Sold out
Trexquant Investment LP0$00.00%−71,224−100.0%Sold out
Credit Suisse AG0$00.00%−61,043−100.0%Sold out
Polar Capital Holdings Plc0$00.00%−37,790−100.0%Sold out
Ikarian Capital, LLC0$00.00%−29,644−100.0%Sold out
Arizona State Retirement System0$00.00%−19,673−100.0%Sold out
Ergoteles LLC0$00.00%−16,945−100.0%Sold out
Walleye Capital LLC0$00.00%−15,482−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−14,884−100.0%Sold out
Janus Henderson Group PLC0$00.00%−13,076−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−11,306−100.0%Sold out
Provident Investment Management, Inc.0$00.00%−10,850−100.0%Sold out
HRT Financial LP0$00.00%−10,370−100.0%Sold out
Macquarie Group Ltd0$00.00%−8,837−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−8,044−100.0%Sold out
Shell Asset Management Co0$00.00%−5,956−100.0%Sold out
Great West Life Assurance Co0$00.00%−4,020−100.0%Sold out
Quantbot Technologies LP0$00.00%−127−100.0%Sold out
Virginia Retirement Systems Et Al––––Not filed
Golden State Equity Partners––––Not filed
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed